Global Psychedelic Drugs Market

1. Summary

The Global Psychedelic Drugs Market was valued at $4.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 13.6% CAGR, to an estimated market size of $7.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global psychedelic drugs market involves the research, development, and commercialization of substances such as psilocybin, MDMA, ketamine, and LSD for therapeutic use. The scope primarily includes pharmaceutical-grade compounds utilized in psychedelic-assisted therapy to treat mental health conditions like treatment-resistant depression, PTSD, and anxiety, while excluding illicit recreational use.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Psychedelic Drugs Market in the period 2025-30:

• The rising global prevalence of treatment-resistant depression and PTSD is creating a massive unmet need for rapid-acting psychiatric interventions.
• Significant regulatory shifts, including FDA breakthrough therapy designations and decriminalization efforts, are accelerating clinical development timelines.
• Increasing institutional investment from major pharmaceutical companies and venture capital is fueling robust R&D pipelines and commercial infrastructure.
• The expansion of specialized clinics and telehealth platforms is improving patient access to supervised psychedelic-assisted therapy sessions.
• Development of next-generation molecules aims to retain therapeutic benefits while reducing hallucinogenic intensity to facilitate broader medical adoption.
• A growing focus on reimbursement frameworks and insurance coverage is essential for transitioning psychedelics from clinical trials to mainstream healthcare.
• The integration of artificial intelligence and machine learning is being utilized to optimize drug discovery and personalize patient treatment protocols.

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: